Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

R1 RCM stock price, quote, forecast and news

RCM
US7493971052
A2DK8W

Price

14.18
Today +/-
+0.02
Today %
+0.14 %
P

R1 RCM stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the R1 RCM stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the R1 RCM stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the R1 RCM stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze R1 RCM's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

R1 RCM Stock Price History

DateR1 RCM Price
9/18/202414.18 undefined
9/17/202414.16 undefined
9/16/202414.18 undefined
9/13/202414.12 undefined
9/12/202414.12 undefined
9/11/202414.12 undefined
9/10/202414.10 undefined
9/9/202414.04 undefined
9/6/202414.07 undefined
9/5/202414.08 undefined
9/4/202414.07 undefined
9/3/202414.09 undefined
8/30/202414.11 undefined
8/29/202414.08 undefined
8/28/202414.06 undefined
8/27/202414.06 undefined
8/26/202414.04 undefined
8/23/202414.04 undefined
8/22/202414.08 undefined
8/21/202414.06 undefined

R1 RCM Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into R1 RCM, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by R1 RCM from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects R1 RCM’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of R1 RCM. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into R1 RCM’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing R1 RCM’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on R1 RCM’s growth potential.

R1 RCM Revenue, EBIT and net profit per share

DateR1 RCM RevenueR1 RCM EBITR1 RCM Net Income
2030e4.87 B undefined0 undefined0 undefined
2029e4.09 B undefined0 undefined0 undefined
2028e4.11 B undefined0 undefined387.96 M undefined
2027e3.73 B undefined715.24 M undefined289.91 M undefined
2026e3.51 B undefined426.34 M undefined146.15 M undefined
2025e2.94 B undefined418.71 M undefined227.38 M undefined
2024e2.56 B undefined296.76 M undefined-88.54 M undefined
20232.25 B undefined260.9 M undefined3.3 M undefined
20221.81 B undefined178.8 M undefined-57.6 M undefined
20211.47 B undefined185 M undefined-495.1 M undefined
20201.27 B undefined143.9 M undefined47.4 M undefined
20191.19 B undefined92.7 M undefined-8.7 M undefined
2018868.5 M undefined-500,000 undefined-64.4 M undefined
2017449.8 M undefined-22.9 M undefined-76.5 M undefined
2016592.6 M undefined302.6 M undefined65.4 M undefined
2015117.2 M undefined-130.3 M undefined-84.3 M undefined
2014210.1 M undefined-49.3 M undefined-79.6 M undefined
2013504.8 M undefined204.1 M undefined130.1 M undefined
201272.3 M undefined-187.9 M undefined-119.7 M undefined
2011102 M undefined-120 M undefined-71.7 M undefined
201026.9 M undefined-126.5 M undefined-79.9 M undefined
200922 M undefined-96.2 M undefined-18 M undefined
2008398.5 M undefined2.8 M undefined-6.9 M undefined
2007240.7 M undefined-500,000 undefined300,000 undefined
2006160.7 M undefined-8.7 M undefined-7.3 M undefined
2005111.2 M undefined-3.2 M undefined-2.7 M undefined

R1 RCM Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e2030e
0.110.160.240.40.020.030.10.070.50.210.120.590.450.871.191.271.471.812.252.562.943.513.734.114.094.87
-44.1450.0065.83-94.4718.18292.31-29.41600.00-58.33-44.29405.98-24.1693.3236.647.0816.0622.5224.8113.7514.7019.386.2710.24-0.5118.94
12.6111.8817.9215.83-295.45-330.77-54.90-161.1163.1013.33-43.5966.227.3511.1816.6919.6121.1019.9921.47-------
14194363-65-86-56-11631828-5139233971982493113614840000000
-3-802-96-126-120-187204-49-130302-22092143185178260128271426715000
-2.70-5.00-0.50-436.36-484.62-117.65-259.7240.48-23.33-111.1151.01-4.90-7.7611.2612.559.8611.544.999.2112.1319.16---
-2-70-6-18-79-71-119130-79-8465-76-64-847-495-573-8822714628938700
-250.00--200.00338.89-10.1367.61-209.24-160.776.33-177.38-216.92-15.79-87.50-687.50-1,153.19-88.48-105.26-3,033.33-357.95-35.6897.9533.91--
19.325.940.436.136.770.79798.696.895.896.8100.2102.1108.2111.5174.6266.2352.3454.090000000
--------------------------
Details

Keystats

ⓘ

Revenue and Growth

The R1 RCM Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the R1 RCM is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
20072008200920102011201220132014201520162017201820192020202120222023
                                 
34.751.743.7156.1196.7177228.9145.2104.5181.2164.962.892173.8130.1110.1173.6
16.821.535.317.125.924.64.410.25.823.697.485.1122.2157.4344.1363.8
0000000000045.100127.1
00000000000000000
1.42.419.932.4203.2274.2121.780.81217.613.832.634.559.477.298.388.8
52.975.666.6193.8417477.1375.2230.4126.7204.6202.3196.8216.7355.4364.7564.5633.3
4.68.98.41517.221.416.314.627.232.848.395.2194.8151.5143.6245.3236.2
00000000000000000
0000000000000003237.7
000000000000.180.160.170.271.511.31
000000000000.250.250.380.552.662.63
1.9184.5135.241.558.4118201.2302.3177.785.480.299.7135.7120.9125.3112.9
0.010.010.090.150.060.080.130.220.330.210.130.610.710.831.084.584.33
0.060.090.160.340.480.560.510.450.460.420.340.810.931.191.455.144.96
                                 
0.10.10.10.911111.1172.8190.5209.6230.4252.934.44.5
0.030.040.050.160.230.260.280.310.320.350.340.360.370.390.633.123.2
-16.2-30.1-176.6-256.5-328.2-448-317.9-397.5-481.8-304.7-244.5-289.8-277.8-161.5-64.3-121.9-136.7
-0.3-0.5-0.20-0.7-0.8-1.5-1.8-2.5-2.8-1.6-3.5-4.5-6.5-5.3-3.4-5.9
00000000000000000
0.020.01-0.12-0.1-0.1-0.19-0.04-0.09-0.160.210.280.280.320.480.5633.06
22.118.11.12.51.30.94.312.55.37.97.29.920.218.217.733.422.7
10.137.915.617.323.430.231.930.724.843.354.5103.3139.1121.9161.3182.1205.7
12.72361.482.9488676.6356.7220202.583.928.265.848.13249.464.945
0000000000014.581.98.315.55.8
000000000002.717.132.317.553.967
44.97978.1102.7512.7707.7392.9263.2232.6135.189.9196.2232.5206.3254.2349.8346.2
000000000000.360.340.520.751.731.57
000000000000000200.7176.6
00206.7337.665.185.8202.8325.5441120.723.440.6111.1123.693.5136.2115.5
000.210.340.070.090.20.330.440.120.020.40.450.640.852.071.86
0.040.080.280.440.580.790.60.590.670.260.110.590.680.851.12.422.21
0.060.090.160.340.480.610.560.50.510.470.40.8711.331.665.425.27
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of R1 RCM provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand R1 RCM's financial health and stability.

Assets

R1 RCM's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that R1 RCM must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of R1 RCM after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into R1 RCM's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (k)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200620072008200920102011201220132014201520162017201820192020202120222023
-7011412-71-119130-79-84177-58-451211797-573
0123646668101638556877172278
000-3-3-74-7679-49-5212129-14-5-123-6-14
11328-1112151198-1871777-4272217-2-121-16-241-72
0610182126465055566121397223159189217
0000000000002326151761126
001891112-1-1-1-2-3-45834
611391532112954-77-23-86201811361264-9340
-1-3-6-7-15-7-10-1-6-21-12-33-33-61-49-51-101-102
-4-3-6-7-16-7-10-1-6-22-11-33-496-61-117-340-949-102
-3,000000-1,0000000-1,0001,0000-462,0000-67,000-288,000-847,0000
000000000000000000
0000000000000.36-0.030.20.221.01-0.15
25-108517-42000-2-2231318-152-341
25-16-169736-38004176-4377-2513731943-173
00-14-1611184005178-1-3-11-76-35-33-21
000000000000000000
31316-811140-1951-83-4177-16-1012782-44-2063
4.78.332.77.2174.318.752.5-83.2-45.1-99.5-12.7-15.252.912.5213.1-111.7237.6
000000000000000000

R1 RCM stock margins

The R1 RCM margin analysis displays the gross margin, EBIT margin, as well as the profit margin of R1 RCM. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for R1 RCM.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the R1 RCM's sales revenue. A higher gross margin percentage indicates that the R1 RCM retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the R1 RCM's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the R1 RCM's total revenue generated. When comparing the revenue margin year over year, investors can gauge the R1 RCM's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the R1 RCM. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the R1 RCM's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

R1 RCM Margin History

R1 RCM Gross marginR1 RCM Profit marginR1 RCM EBIT marginR1 RCM Profit margin
2030e21.49 %0 %0 %
2029e21.49 %0 %0 %
2028e21.49 %0 %9.43 %
2027e21.49 %19.17 %7.77 %
2026e21.49 %12.14 %4.16 %
2025e21.49 %14.24 %7.73 %
2024e21.49 %11.57 %-3.45 %
202321.49 %11.57 %0.15 %
202220 %9.9 %-3.19 %
202121.14 %12.55 %-33.58 %
202019.65 %11.32 %3.73 %
201916.72 %7.82 %-0.73 %
201811.27 %-0.06 %-7.42 %
20177.45 %-5.09 %-17.01 %
201666.3 %51.06 %11.04 %
2015-44.11 %-111.18 %-71.93 %
201413.33 %-23.47 %-37.89 %
201363 %40.43 %25.77 %
2012-161 %-259.89 %-165.56 %
2011-55.59 %-117.65 %-70.29 %
2010-322.3 %-470.26 %-297.03 %
2009-298.64 %-437.27 %-81.82 %
200815.88 %0.7 %-1.73 %
200717.86 %-0.21 %0.12 %
200611.82 %-5.41 %-4.54 %
200512.68 %-2.88 %-2.43 %

R1 RCM Stock Sales Revenue, EBIT, Earnings per Share

The R1 RCM earnings per share therefore indicates how much revenue R1 RCM has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue R1 RCM earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates R1 RCM's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of R1 RCM’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating R1 RCM's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

R1 RCM Revenue, EBIT and net profit per share

DateR1 RCM Sales per ShareR1 RCM EBIT per shareR1 RCM Earnings per Share
2030e11.53 undefined0 undefined0 undefined
2029e9.69 undefined0 undefined0 undefined
2028e9.74 undefined0 undefined0.92 undefined
2027e8.84 undefined0 undefined0.69 undefined
2026e8.32 undefined0 undefined0.35 undefined
2025e6.97 undefined0 undefined0.54 undefined
2024e6.07 undefined0 undefined-0.21 undefined
20234.96 undefined0.57 undefined0.01 undefined
20225.13 undefined0.51 undefined-0.16 undefined
20215.54 undefined0.69 undefined-1.86 undefined
20207.28 undefined0.82 undefined0.27 undefined
201910.64 undefined0.83 undefined-0.08 undefined
20188.03 undefined-0 undefined-0.6 undefined
20174.41 undefined-0.22 undefined-0.75 undefined
20165.91 undefined3.02 undefined0.65 undefined
20151.21 undefined-1.35 undefined-0.87 undefined
20142.19 undefined-0.51 undefined-0.83 undefined
20135.21 undefined2.11 undefined1.34 undefined
20120.73 undefined-1.91 undefined-1.21 undefined
20111.05 undefined-1.24 undefined-0.74 undefined
20100.38 undefined-1.79 undefined-1.13 undefined
20090.6 undefined-2.62 undefined-0.49 undefined
200811.04 undefined0.08 undefined-0.19 undefined
20075.96 undefined-0.01 undefined0.01 undefined
20066.2 undefined-0.34 undefined-0.28 undefined
20055.76 undefined-0.17 undefined-0.14 undefined

R1 RCM business model

R1 RCM Inc is an American company that operates in the healthcare services sector. It was founded in 2003 as Accretive Health and is headquartered in Chicago, Illinois. R1 RCM's business model focuses on providing services in the area of Revenue Cycle Management (RCM). This involves managing the payment process between patients, insurance companies, and medical service providers. R1 RCM offers its customers a comprehensive range of RCM services, including Revenue Cycle Analytics, Patient Access, and Revenue Cycle Outsourcing. With this service, R1 RCM provides a solution for all types of customers. The various divisions of R1 RCM include Revenue Cycle Services, Physician Advisory Services, Revenue Integrity, and Population Health. R1 RCM's Revenue Cycle Services encompass both RCM technology and services such as patient billing, revenue cycle outsourcing, coding, and documentation. Physician Advisory Services were created to add value to clinical decisions and build a collaborative partnership between physicians and R1 RCM. Revenue Integrity focuses on auditing billing errors and identifying additional services to improve reimbursement. Population Health focuses on managing population health analytics to determine which patients should be targeted with specific RCM technologies and services. The products offered by R1 RCM help customers streamline the revenue cycle and reduce costs. R1 RCM's product range includes RCM technology, outsourcing services, consulting services, and training materials. These products are used by R1 RCM to enhance the efficiency and effectiveness of RCM processes by simplifying billing, improving cash flow, and strengthening customer retention. R1 RCM has shown positive growth in recent years and acquired Intermedix Corp. in 2017. The acquisition was a significant step for R1 RCM in the post-acute care and ambulatory medical services sector, helping the company expand its business in the retail segment. Overall, R1 RCM has a solid business operation, and the services it offers are indispensable for many medical service providers. With improved technologies and continuous business model enhancements, R1 RCM has the opportunity to continue growing in the coming years. R1 RCM is one of the most popular companies on Eulerpool.com.

R1 RCM SWOT Analysis

Strengths

R1 RCM Inc, a leading provider of revenue cycle management services, possesses several key strengths:

  • Strong market presence and reputation in the healthcare industry.
  • Extensive experience and expertise in revenue cycle management.
  • Advanced technology solutions that improve efficiency and accuracy.
  • Strategic partnerships with major healthcare organizations.

Weaknesses

Despite its strengths, R1 RCM Inc faces some weaknesses:

  • Dependence on a limited number of major clients for a significant portion of its revenue.
  • Potential vulnerability to changes in healthcare policies and regulations.
  • Relatively high operating costs due to the need for continuous investment in technology and talent.

Opportunities

R1 RCM Inc can capitalize on the following opportunities:

  • Expanding into international markets to diversify revenue sources.
  • Growing demand for outsourcing revenue cycle management services due to increasing complexities in healthcare reimbursement.
  • Developing innovative solutions to address emerging trends in healthcare, such as value-based care.

Threats

R1 RCM Inc faces certain threats that could impact its business:

  • Intense competition from established players and new entrants in the revenue cycle management industry.
  • Economic downturns or changes in healthcare spending that could reduce demand for services.
  • Risks associated with data security and privacy breaches, given the sensitive nature of healthcare information.

R1 RCM Revenue by Segment

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

R1 RCM Revenue by Segment

Segmente20232022
Net operating fees1.46 B USD1.31 B USD
Modular and other fees689.9 M USD-
Modular and other-389.9 M USD
Incentive fees108.4 M USD106.8 M USD

R1 RCM Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

R1 RCM historical P/E ratio, EBIT, and P/S ratio.

R1 RCM shares outstanding

The number of shares was R1 RCM in 2023 — This indicates how many shares 454.094 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue R1 RCM earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates R1 RCM's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of R1 RCM’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating R1 RCM's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

R1 RCM Stock splits

In R1 RCM's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for R1 RCM.

Eulerpool ESG Scorecard© for the R1 RCM stock

Eulerpool World ESG Rating (EESG©)

49/ 100

🌱 Environment

55

👫 Social

63

🏛️ Governance

29

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees50
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management9.3
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share5.8
Percentage of Black employees—
Black Management Share6.5
Percentage of white employees—
White Management Share75
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

R1 RCM list of shareholders

%
Name
Stocks
Change
Date
3.58008 % BlackRock Institutional Trust Company, N.A.15,111,882901,10012/31/2022
25.89117 % TowerBrook Capital Partners, L.P.109,289,200-30,000,0009/13/2022
22.36592 % New Mountain Capital, LLC94,408,780-20,80912/31/2022
2.78590 % Citadel Advisors LLC11,759,5786,737,02412/31/2022
2.66162 % The Vanguard Group, Inc.11,234,955-2,728,87112/31/2022
2.56322 % Point72 Asset Management, L.P.10,819,6009,505,90012/31/2022
1.86606 % Fidelity Management & Research Company LLC7,876,834874,72912/31/2022
1.60859 % Sachem Head Capital Management LP6,790,0006,790,00012/31/2022
1.23411 % American Century Investment Management, Inc.5,209,2851,660,66312/31/2022
1.12944 % State Street Global Advisors (US)4,767,471300,72212/31/2022
1
2
3
4
5
...
10

R1 RCM Executives and Management Board

Mr. Joseph Flanagan51
R1 RCM Director (since 2013)
Compensation 7.62 M
Mr. John Sparby47
R1 RCM President
Compensation 3.66 M
Mr. Lee Rivas48
R1 RCM Chief Executive Officer, Director (since 2023)
Compensation 3.38 M
Mr. Anthony Speranzo74
R1 RCM Chairman of the Board (since 2016)
Compensation 400,000
Mr. John Henneman61
R1 RCM Lead Independent Director
Compensation 227,500
1
2
3
4

R1 RCM Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Aukett Swanke Group Stock
Aukett Swanke Group
SupplierCustomer-0,260,400,120,12-0,06
MEDNAX Stock
MEDNAX
SupplierCustomer0,660,650,890,31-0,460,48
1

Most common questions regarding R1 RCM

What values and corporate philosophy does R1 RCM represent?

R1 RCM Inc represents a strong commitment to values and an effective corporate philosophy. The company prioritizes customer satisfaction by delivering high-quality services and innovative solutions. R1 RCM Inc focuses on integrity, ensuring transparency in its operations and maintaining trust with its stakeholders. The company also emphasizes teamwork, encouraging collaboration and fostering a positive work environment. R1 RCM Inc is dedicated to continuous improvement, constantly evolving and adapting to the changing needs of the healthcare industry. With a customer-centric approach and a dedication to excellence, R1 RCM Inc strives to be a leader in the healthcare revenue cycle management sector.

In which countries and regions is R1 RCM primarily present?

R1 RCM Inc is primarily present in the United States.

What significant milestones has the company R1 RCM achieved?

R1 RCM Inc has achieved significant milestones throughout its journey. The company has successfully positioned itself as a leader in the healthcare revenue cycle management industry. R1 RCM Inc has expanded its client base by forging strategic partnerships with various healthcare providers, enhancing its market presence and reputation. With a relentless focus on innovation and technology, R1 RCM Inc has achieved remarkable financial growth and operational efficiency. The company's commitment to delivering exceptional value and results has earned it recognition as one of the top performers in the industry. Overall, R1 RCM Inc has consistently surpassed expectations and continues to pave the way for excellence in healthcare revenue cycle management.

What is the history and background of the company R1 RCM?

R1 RCM Inc, formerly known as Accretive Health Inc, is a leading provider of revenue cycle management solutions for healthcare organizations. Founded in 2003, R1 RCM Inc offers a comprehensive suite of services designed to optimize the financial performance of healthcare providers, including hospitals and physician groups. With its extensive expertise and advanced technology platforms, R1 RCM Inc helps its clients improve revenue capture, reduce costs, and enhance patient satisfaction. Over the years, R1 RCM Inc has established itself as a trusted partner in the healthcare industry, serving clients across the United States.

Who are the main competitors of R1 RCM in the market?

The main competitors of R1 RCM Inc in the market include Allscripts Healthcare Solutions, Cerner Corporation, and McKesson Corporation.

In which industries is R1 RCM primarily active?

R1 RCM Inc is primarily active in the healthcare industry.

What is the business model of R1 RCM?

The business model of R1 RCM Inc revolves around providing revenue cycle management (RCM) solutions for healthcare organizations. R1 RCM offers end-to-end RCM services, including patient registration, coding, billing, and collections. By leveraging advanced technology and data analytics, R1 RCM helps healthcare providers optimize their financial performance, improve the patient experience, and enhance overall operational efficiency. With a focus on delivering value-based care, R1 RCM's business model is centered on driving revenue growth and financial sustainability for healthcare institutions.

What is the P/E ratio of R1 RCM 2024?

The R1 RCM P/E ratio is -72.73.

What is the P/S ratio of R1 RCM 2024?

The R1 RCM P/S ratio is 2.51.

What is the AlleAktien quality score of R1 RCM?

The AlleAktien quality score for R1 RCM is 4/10.

What is the revenue of R1 RCM 2024?

The expected R1 RCM revenue is 2.56 B USD.

How high is the profit of R1 RCM 2024?

The expected R1 RCM profit is -88.54 M USD.

What is the business model of R1 RCM

R1 RCM is a leading company in the field of medical services and offers innovative solutions in the areas of billing, coding, process optimization, and patient registration. The business model of R1 RCM is based on providing services across various sectors. These include Revenue Cycle Management, Physician Advisory Services, Clinical Documentation Improvement, and Patient Registration. The company aims to support hospitals, clinics, and healthcare organizations in improving their operations while simultaneously reducing costs and enhancing the quality of care. Revenue Cycle Management is one of the key sectors of R1 RCM. The company provides comprehensive billing services that encompass the entire billing process, from capturing patient information to monitoring payment receipts. R1 RCM utilizes the latest technologies and automated processes to minimize errors and maximize efficiency. Physician Advisory Services is another sector of R1 RCM that focuses on optimizing medical documentation. Here, physicians and professionals collaborate to ensure that diagnoses and treatments are correctly documented and coded to ensure accurate billing and improve the quality of patient care. Clinical Documentation Improvement is another significant area of R1 RCM. In this sector, the company works to enhance the quality of medical documentation and the accuracy of diagnoses and treatments. By utilizing technology and analytical tools, the correct capture of information and data is ensured to optimize billing and enhance patient-related decision-making. Patient Registration is a crucial component of the R1 RCM business model. Patient information is captured and documented here to ensure smooth operations and accurate billing. By integrating technology and automation, R1 RCM is able to increase efficiency and reduce patient wait times. In addition to these services, R1 RCM also offers products specifically tailored to the needs of healthcare organizations. These include a medical coding platform, a patient registration platform, and a comprehensive data analysis platform that allows the company to gain valuable insights into operational processes. Overall, the business model of R1 RCM is focused on improving the efficiency and quality of care while simultaneously reducing costs. By leveraging technology, analytical tools, and automated processes, the company is able to support its clients optimally while also exploring new business opportunities.

What is the R1 RCM dividend?

R1 RCM pays a dividend of 0 USD distributed over payouts per year.

How often does R1 RCM pay dividends?

The dividend cannot currently be calculated for R1 RCM or the company does not pay out a dividend.

What is the R1 RCM ISIN?

The ISIN of R1 RCM is US7493971052.

What is the R1 RCM WKN?

The WKN of R1 RCM is A2DK8W.

What is the R1 RCM ticker?

The ticker of R1 RCM is RCM.

How much dividend does R1 RCM pay?

Over the past 12 months, R1 RCM paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, R1 RCM is expected to pay a dividend of 0 USD.

What is the dividend yield of R1 RCM?

The current dividend yield of R1 RCM is .

When does R1 RCM pay dividends?

R1 RCM pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of R1 RCM?

R1 RCM paid dividends every year for the past 0 years.

What is the dividend of R1 RCM?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is R1 RCM located?

R1 RCM is assigned to the 'Health' sector.

Wann musste ich die Aktien von R1 RCM kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of R1 RCM from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did R1 RCM pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of R1 RCM in the year 2023?

In the year 2023, R1 RCM distributed 0 USD as dividends.

In which currency does R1 RCM pay out the dividend?

The dividends of R1 RCM are distributed in USD.

All fundamentals about R1 RCM

Our stock analysis for R1 RCM Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of R1 RCM Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.